INFLUENCE OF DIFFERENT INTERFERON-GAMMA (IFN-γ) CONCENTRATIONS ON CELLS OF THE IMMUNE SYSTEM IN VITRO
- Authors: Sitkovskaya A.O.1, Sagakyants A.B.1, Filippova S.Y.1, Mezhevova I.V.1, Bondarenko E.S.1, Statsenko K.G.1, Popova M.M.1
-
Affiliations:
- Rostov Research Institute of Oncology
- Issue: Vol 22, No 2-2 (2019)
- Pages: 921-923
- Section: ORIGINAL ARTICLES
- Submitted: 24.07.2020
- Accepted: 24.07.2020
- Published: 15.07.2019
- URL: https://rusimmun.ru/jour/article/view/406
- DOI: https://doi.org/10.31857/S102872210006541-0
- ID: 406
Cite item
Full Text
Abstract
About the authors
A. O. Sitkovskaya
Rostov Research Institute of Oncology
Author for correspondence.
Email: grankina.anastasia@mail.ru
Head of the Cell Technology Laboratory,
Rostov-on-Don
Russian FederationA. B. Sagakyants
Rostov Research Institute of Oncology
Email: fake@neicon.ru
Ph.D., Head of the Laboratory of tumor immunophenotyping,
Rostov-on-Don
Russian FederationS. Yu. Filippova
Rostov Research Institute of Oncology
Email: fake@neicon.ru
Researcher, Laboratory of Cell Technologies of the laboratory of tumor immunophenotyping,
Rostov-on-Don
Russian FederationI. V. Mezhevova
Rostov Research Institute of Oncology
Email: fake@neicon.ru
Junior researcher of the Laboratory of tumor immunophenotyping,
Rostov-on-Don
Russian FederationE. S. Bondarenko
Rostov Research Institute of Oncology
Email: fake@neicon.ru
Junior researcher of the Laboratory of tumor immunophenotyping,
Rostov-on-Don
Russian FederationK. G. Statsenko
Rostov Research Institute of Oncology
Email: fake@neicon.ru
student,
Rostov-on-Don
Russian FederationM. M. Popova
Rostov Research Institute of Oncology
Email: fake@neicon.ru
student,
Rostov-on-Don
Russian FederationReferences
- Gama H. P., Rocha A. J., Silva C. J., Mendes M. F., Veiga I. C., Lancelotti C. I., Andrande V. P., Tibery C. P. Meningioma growth during interferon beta-1A treatment for multiple sclerosis. Arq Neuropsiquiatr. 2008, 66(2B), 402–404.
- Мухачева М. В., Бейн Б. Н. Роль интерферонов в противоопухолевом иммунитете у больных с церебральными опухолями. Фундаментальные исследования. 2015, 1(7), 1486–1490.
- Златник Е. Ю., Ситковская А. О., Непомнящая Е. М., Джандигова Ф. Р., Ващенко Л. Н. Достижения и перспективы клеточных технологий на основе активированных лимфоцитов в лечении злокачественных опухолей. Казанский медицинский журнал. 2018, 5, 792–801.